Drugs such as semaglutide are an important and valid weight management tool for those living with or at risk of type 2 diabetes, and people should be supported to find the approach that is most appropriate for them. In August, Novo Nordisk published the findings of its own five-year study on Wegovy, known as the Select trial
A NEW randomized clinical trial suggests that once-weekly semaglutide may help reduce alcohol consumption and cravings in adults with alcohol use disorder (AUD)
Here's the catch: your glutathione levels drop sharply after 40, and the decline accelerates every decade
Its a complex landscape where careful consideration of drug interactions is not just important, but absolutely essential for safety and efficacy
If progress stalls, a modest increase might help
Its multifaceted effects stem from its impact on inflammatory cytokines and mitochondrial function 1